Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirin Kalimuddin

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
JCI Insight|May 5, 2017
18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment responseAnn-Marie Chacko, Satoru Watanabe, Keira J Herr, et al.
Vaccine|November 28, 2017
A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimenShirin Kalimuddin, Limin Wijaya, Yvonne F Z Chan, et al.
Communications Medicine|May 23, 2026
Aminoglycosides induce immune activation but is insufficient for systemic viral control: a double-blind randomized-controlled clinical trialPunitha Sivanandam, Ayesa Syenina, Yvonne Fz Chan, et al.
Antiviral Research|December 6, 2020
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography as a window into human dengue pathophysiologyShirin Kalimuddin, Wanying Xie, Satoru Watanabe, et al.
Scientific Reports|July 14, 2016
Differential host susceptibility and bacterial virulence factors driving Klebsiella liver abscess in an ethnically diverse populationI Russel Lee, James S Molton, Kelly L Wyres, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 5, 2021
Validation of self-collected buccal swab and saliva as a diagnostic tool for COVID-19Chee Wai Ku, Durai Shivani, Jacqueline Q T Kwan, et al.
Vaccine|December 18, 2019
Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trialVianney Tricou, Jenny G Low, Helen M Oh, et al.
Allergy|September 3, 2022
In vitro vaccine challenge of PBMCs from BNT162b2 anaphylaxis patients reveals HSP90α-NOD2-NLRP3 nexusHui Ling Ko, Nicole Zhuo, Zi Wei Chang, et al.
Ebiomedicine|February 21, 2023
Early peripheral blood MCEMP1 and HLA-DRA expression predicts COVID-19 prognosisKuan Rong Chan, Clara W T Koh, Dorothy H L Ng, et al.
Cell Host & Microbe|May 4, 2020
A Dynamic Immune Response Shapes COVID-19 ProgressionEugenia Ziying Ong, Yvonne Fu Zi Chan, Wan Ying Leong, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
JCI Insight|May 5, 2017
18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment responseAnn-Marie Chacko, Satoru Watanabe, Keira J Herr, et al.
Vaccine|November 28, 2017
A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimenShirin Kalimuddin, Limin Wijaya, Yvonne F Z Chan, et al.
Communications Medicine|May 23, 2026
Aminoglycosides induce immune activation but is insufficient for systemic viral control: a double-blind randomized-controlled clinical trialPunitha Sivanandam, Ayesa Syenina, Yvonne Fz Chan, et al.
Antiviral Research|December 6, 2020
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography as a window into human dengue pathophysiologyShirin Kalimuddin, Wanying Xie, Satoru Watanabe, et al.
Scientific Reports|July 14, 2016
Differential host susceptibility and bacterial virulence factors driving Klebsiella liver abscess in an ethnically diverse populationI Russel Lee, James S Molton, Kelly L Wyres, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 5, 2021
Validation of self-collected buccal swab and saliva as a diagnostic tool for COVID-19Chee Wai Ku, Durai Shivani, Jacqueline Q T Kwan, et al.
Vaccine|December 18, 2019
Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trialVianney Tricou, Jenny G Low, Helen M Oh, et al.
Allergy|September 3, 2022
In vitro vaccine challenge of PBMCs from BNT162b2 anaphylaxis patients reveals HSP90α-NOD2-NLRP3 nexusHui Ling Ko, Nicole Zhuo, Zi Wei Chang, et al.
Ebiomedicine|February 21, 2023
Early peripheral blood MCEMP1 and HLA-DRA expression predicts COVID-19 prognosisKuan Rong Chan, Clara W T Koh, Dorothy H L Ng, et al.
Cell Host & Microbe|May 4, 2020
A Dynamic Immune Response Shapes COVID-19 ProgressionEugenia Ziying Ong, Yvonne Fu Zi Chan, Wan Ying Leong, et al.
Pageof 10